1. Gagandeep, S., & Dheeraj, K. (2009). Neurology of acute organophosphate poisoning. Neurology India, 57, 119–125.
2. Vijayakumar, S., Fareedullah, M., Venkateswarlu, B., Sudhakar, Y., & Ashok kumar, E. (2010). Current review on organophosphorus poisoning. Archives of Applied Science Research., 2(4), 199–215.
3. Comroe, J. H., Todd, J., Gammon, G. D., Leopold, I. H., Koelle, G. B., & Bodansky, O. (1946). The effect of di-isopropyl-fluorphosphate (DFP) upon patients with myasthenia gravis. American Journal of the Medical Sciences, 212, 641–651.
4. Grob, D., & Harvey, A. M. (1949). Observations on the effects of tetraethyl pyrophosphate (TEPP) in man and on its use in treatment of myasthenia gravis. Bull Johns Hopkins Hospital, 84, 533–567.
5. Rider, J. A., Schulman, S., Richtern, R. B., Moeller, H. D., & Du Bois, K. P. (1951). Treatment of myasthenia gravis with octainethyl pyrophosphoramide. JAMA, 145, 967–972.